Howard Capital Management (New York)’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Howard Capital Management (New York)’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$5.96M	Sell	52,503 -4,894	-9%	-$534K	0.67%	35
2020 Q3	$6.05M	Buy	57,397 +376	+0.7%	+$39.6K	0.76%	35
2020 Q2	$5.71M	Buy	57,021 +634	+1%	+$62.6K	0.76%	34
2020 Q1	$5M	Sell	56,387 -882	-2%	-$85.7K	0.85%	33
2019 Q4	$5.83M	Sell	57,269 -254	-0.4%	-$24.4K	0.73%	39
2019 Q3	$5.18M	Sell	57,523 -1,437	-2%	-$131K	0.74%	39
2019 Q2	$5.46M	Buy	58,960 +236	+0.4%	+$21.2K	0.75%	40
2019 Q1	$5.39M	Sell	58,724 -12,244	-17%	-$1.1M	0.76%	40
2018 Q4	$6.14M	Sell	70,968 -1,344	-2%	-$122K	1.01%	35
2018 Q3	$6.88M	Sell	72,312 -119,966	-62%	-$10.8M	0.92%	40
2018 Q2	$16M	Buy	192,278 +2,368	+1%	+$196K	2.31%	14
2018 Q1	$15.5M	Buy	189,910 +8,037	+4%	+$685K	2.25%	17
2017 Q4	$15M	Buy	181,873 +106,303	+141%	+$8.76M	2.21%	19
2017 Q3	$6.18M	Buy	75,570 +1,431	+2%	+$115K	0.95%	40
2017 Q2	$5.88M	Buy	74,139 +3,931	+6%	+$300K	0.92%	42
2017 Q1	$5.22M	Buy	70,208 +2,370	+3%	+$173K	0.87%	41
2016 Q4	$4.68M	Buy	67,838 +3,396	+5%	+$236K	0.83%	42
2016 Q3	$4.65M	Buy	64,442 +1,691	+3%	+$124K	0.84%	41
2016 Q2	$4.5M	Sell	62,751 -2,209	-3%	-$156K	0.86%	40
2016 Q1	$4.4M	Buy	64,960 +4,376	+7%	+$293K	0.86%	41
2015 Q4	$4.36M	Buy	60,584 +3,431	+6%	+$242K	0.86%	42
2015 Q3	$3.79M	Buy	57,153 +2,300	+4%	+$168K	0.77%	44
2015 Q2	$4.08M	Buy	54,853 +2,855	+5%	+$212K	0.78%	44
2015 Q1	$3.77M	Buy	51,998 +3,968	+8%	+$283K	0.73%	43
2014 Q4	$3.28M	Buy	48,030 +1,781	+4%	+$119K	0.63%	45
2014 Q3	$2.96M	Buy	46,249 +701	+2%	+$43.9K	0.59%	43
2014 Q2	$2.77M	Buy	45,548 +1,006	+2%	+$59.1K	0.55%	46
2014 Q1	$2.6M	Buy	44,542 +2,935	+7%	+$169K	0.51%	49
2013 Q4	$2.31M	Buy	41,607 +1,036	+3%	+$55.4K	0.47%	48
2013 Q3	$2.05M	Sell	40,571 -863	-2%	-$43.4K	0.5%	47
2013 Q2	$1.97M	Buy	+41,434	New	+$1.98M	0.52%	47

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NLI

Nippon Life Insurance Tokyo, Japan $6.04B AUM 4.21% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Howard Capital Management (New York)'s XLV Position: Q4 2020 in Review

Howard Capital Management (New York) reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 8.5% in Q4 2020, selling an estimated $534K and leaving 52,503 shares worth $5.96M. The position accounts for 0.67% of the portfolio, ranked #35.

Howard Capital Management (New York) first reported a position in XLV in Q2 2013 and has held it in 31 quarters since. The position peaked at $16M in Q2 2018. 1,168 funds tracked by Wall St. Rank hold XLV as of Q4 2020.

Howard Capital Management (New York) held 52,503 shares of State Street Health Care Select Sector SPDR ETF worth $5.96M as of Q4 2020.
Howard Capital Management (New York) sold 4,894 State Street Health Care Select Sector SPDR ETF shares in Q4 2020, an estimated $534K.
State Street Health Care Select Sector SPDR ETF made up 0.67% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #35 holding.
Howard Capital Management (New York) first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 31 quarters since.
Howard Capital Management (New York)'s State Street Health Care Select Sector SPDR ETF position peaked at $16M in Q2 2018.
1,168 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q4 2020.

Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.